ロード中...

An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations

In the context of an increasing repertoire of multiple sclerosis (MS) therapeutics, choosing the appropriate treatment for an individual patient is becoming increasingly challenging. Natalizumab, a humanized monoclonal antibody directed against alpha4beta1 integrin, has proven short-term and long-te...

詳細記述

保存先:
書誌詳細
出版年:Patient Prefer Adherence
第一著者: Kornek, Barbara
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4446014/
https://ncbi.nlm.nih.gov/pubmed/26056435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S20791
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!